CIABATTONI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 7.479
AS - Asia 4.313
EU - Europa 4.242
SA - Sud America 410
Continente sconosciuto - Info sul continente non disponibili 262
AF - Africa 60
OC - Oceania 4
Totale 16.770
Nazione #
US - Stati Uniti d'America 7.250
SG - Singapore 1.664
CN - Cina 1.221
UA - Ucraina 815
TR - Turchia 646
IE - Irlanda 606
GB - Regno Unito 587
RU - Federazione Russa 510
SE - Svezia 506
FR - Francia 347
BR - Brasile 335
DE - Germania 319
VN - Vietnam 285
IT - Italia 244
FI - Finlandia 200
IN - India 191
CA - Canada 94
BD - Bangladesh 80
MX - Messico 42
HK - Hong Kong 37
AR - Argentina 29
PL - Polonia 24
KR - Corea 21
ZA - Sudafrica 21
IQ - Iraq 19
ID - Indonesia 17
CZ - Repubblica Ceca 15
ES - Italia 15
IL - Israele 15
JP - Giappone 15
PK - Pakistan 15
CR - Costa Rica 14
NL - Olanda 13
SA - Arabia Saudita 13
EC - Ecuador 12
CO - Colombia 11
PH - Filippine 11
GP - Guadalupe 10
HN - Honduras 10
SV - El Salvador 10
EU - Europa 9
JM - Giamaica 9
AT - Austria 8
GT - Guatemala 8
NI - Nicaragua 8
UZ - Uzbekistan 8
IR - Iran 7
SC - Seychelles 7
VE - Venezuela 7
DZ - Algeria 6
JO - Giordania 6
LT - Lituania 6
MA - Marocco 6
TT - Trinidad e Tobago 6
CW - ???statistics.table.value.countryCode.CW??? 5
EG - Egitto 5
KE - Kenya 5
PR - Porto Rico 5
AE - Emirati Arabi Uniti 4
AM - Armenia 4
BE - Belgio 4
LB - Libano 4
OM - Oman 4
PY - Paraguay 4
QA - Qatar 4
TW - Taiwan 4
UY - Uruguay 4
AL - Albania 3
AU - Australia 3
BG - Bulgaria 3
BM - Bermuda 3
BO - Bolivia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MY - Malesia 3
PA - Panama 3
RO - Romania 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
BB - Barbados 2
CI - Costa d'Avorio 2
CL - Cile 2
EE - Estonia 2
GD - Grenada 2
MD - Moldavia 2
PE - Perù 2
AI - Anguilla 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 16.510
Città #
Singapore 1.248
Jacksonville 858
San Jose 784
Chandler 740
Dublin 603
Southend 454
Ashburn 376
Beijing 322
Princeton 314
Izmir 311
Dallas 252
Council Bluffs 247
Nanjing 202
Santa Clara 199
Wilmington 186
Los Angeles 166
Cambridge 144
Dearborn 132
Tongling 107
Buffalo 98
Ho Chi Minh City 94
New York 88
Munich 83
The Dalles 76
Nanchang 74
Woodbridge 69
Moscow 66
Hanoi 61
Ann Arbor 60
Washington 59
Boardman 58
Shenyang 45
Phoenix 42
Altamura 40
Houston 37
São Paulo 35
Brooklyn 34
Hebei 34
Kunming 34
Tianjin 34
Grevenbroich 33
Hong Kong 31
North Bergen 31
Helsinki 30
Changsha 28
Jiaxing 28
Turku 28
Atlanta 26
Montreal 26
Denver 24
Norwalk 24
Orem 21
Chennai 20
Seoul 20
Chicago 19
Kimball 19
Haiphong 18
Hangzhou 18
Rome 18
Warsaw 18
Columbus 17
Redondo Beach 17
Silver Spring 17
Da Nang 16
Hefei 16
Milan 16
Augusta 15
Boston 15
Chieti 15
Mexico City 15
Orange 15
Tokyo 15
Toronto 15
Falls Church 14
Frankfurt am Main 14
Newark 14
Poplar 14
Irving 13
Jinan 13
Johannesburg 13
Philadelphia 13
San Mateo 13
Naples 12
San José 12
Seattle 12
San Francisco 11
Baghdad 10
Brasília 10
Brno 10
Charlotte 10
London 9
Rio de Janeiro 9
Stockholm 9
Belo Horizonte 8
Changchun 8
Lanzhou 8
Milwaukee 8
Richmond 8
Zhengzhou 8
Amsterdam 7
Totale 9.840
Nome #
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 206
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 204
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 189
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 179
Amylin inhibits hypothalamic dopamine release. 170
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 169
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke 168
Determinants of platelet activation in hypertensives with microalbuminuria. 167
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 163
Effect of CART peptide-(55-102), leptin and orexin-B on hypothalamicserotonin release. 162
Aging increases amyloid beta-peptide-induced 8-iso-prostaglandin F2alpha release from rat brain. 162
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 162
Chromatin derived acid peptides inhibit dopamine and norepinephrine release in the hypothalamus. 160
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetes subjects 159
Anterior pituitary cell production of 8-iso-prostaglandin F2alpha. 157
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation 156
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 152
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 151
Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. 150
8-Isoprostane in exhaled breath condensate (EBC)and excercise-induced bronchoconstriction in asthmatic children and adolescents 149
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 149
Cyclooxygenase-1, but not -2, is upregulated in NB4 leukemic cells and human primary promyelocytic blasts during neutrophil granulocytic differentiation and contributes to maturation. 148
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells. 145
Insulin resistance as a determinant of platelet activation in obese women. 144
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 142
Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X 140
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 138
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 137
Decreased plasma soluble rage in patients with hypercholesterolemia: effects of statins. 137
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 137
Soluble RAGE in type 2 diabetes: association with oxidative stress. 136
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 136
Immunological characterization uf urinary 8-epi-prostaglandin f2alfa excretion in man 134
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. 134
Determinants of platelet activation in hypertensives with microalbuminuria. 134
Increased thromboxane biosynthesis in essential thrombocythemia 133
Role of Platelet Activation in Dementia 133
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. 133
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 133
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 132
Platelet Activation and Lipid Peroxidation in Patients With Acute Ischemic Stroke. 131
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 130
Problemi di metodologia per la individuazione del rischio tossicologico. Consiglio Nazionale delle Ricerche 128
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. 128
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control. 127
Association between PAI-1 and Oxidative Stress in Android Obesity 127
Attivazione piastrinica e stress ossidativo in vivo nell’artrite reumatoide. 127
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 127
Determinants of platelet activation in Alzheimer's disease 127
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets. 125
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 125
Acute effects of air pollution on pulmonary function, airway inflammation, and oxidative stress in asthmatic children. 124
Anaphylaxis increases 8-iso-PGF2alpha release from guinea-pig lung in vitro 123
Measurement of 8-isoprostane in exhaled breath condensate. 122
In vivo formation of 8-epi-prostaglandin F2alpha in increased in hypercholesterolemia. An aspirin-insensitive amplification mechanism of platelet activation (pubbl su Suppl Thromb Haemostas) 121
Drugs, prostaglandins, and renal function. 121
Differential Expression and Regulation of Cyclooxygenase Isozymes in Thymic Stromal Cells. 121
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 120
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 120
Exhaled 8-Isoprostane as an In Vivo Biomarker of Lung Oxidative Stress in Patients with COPD and Healthy Smokers 119
Insulin resistance as a determinant of platelet activation in obese women 119
Platelet activation in obese women: role of inflammation and oxidant stress. 118
Effects of anthracyclines on hypothalamic dopamine release. 118
Tachykinin-eicosanoid crosstalk in airway inflammation 117
Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide 117
Increased exhaled 8-isoprostane in childhood asthma. 116
Effects of cocaine- and amphetamine-regulated transcript peptide, leptin and orexins on hypothalamic serotonin release. 116
Thromboxane-dependent CD40L release in type 2 diabetes mellitus 116
Determinants of Thromboxane-Dependent Platelet Activation in Heart Failure. 116
Determinants of Platelet Activation in Heart Failure. 114
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 113
Effect of gherlin and amylin on hypothalamic dopamine, norepinephrine and serotonin release. 111
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes 111
In vivo formation of 8-EPI-prostaglandin F2 alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 111
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control 110
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control 110
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the “Low-HDL” Phenotype 109
Induced sputum, exhaled breath condensate and nasal lavage fluid in electroplating workers exposed to chromium 108
Modulation of the expression and activity of cyclooxygenases in normal and accelerated erytrhopoiesis. 108
Effects of atorvastatin and rosuvastatin on throboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 108
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes. 108
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 107
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 107
Platelet Activation Markers in Patients with Peripheral Arterial Disease. A Prospective Comparison of Different Platelet Function Tests 107
Inherited Macrothrombocytopenia with Distinctive Platelet Ultrastructural and Functional Features 105
Soluble CD40L in Mediterranean Spotted Fever: Relation to oxidative stress and platelet activation. 105
Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma. 104
Validation of leukotriene B4 measurements in exhaled breath condensate. 104
Identification of 8-iso-prostaglandin (PG) F2alfa in rat brain neuronal endings: a possible marker of membrane phospholipid peroxidation. 103
Tachykinin-eicosanoid crosstalk in airway inflammation 103
Determinants of Platelet Activation in Heart Failure. 103
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 103
Identification of 8-iso-prostaglandin F2alpha in rat brain neuronal endings: a possible marker of membrane phospholipid peroxidation. 102
Increased macrothrombocytopenia with distinctive platelet ultrastructural and functional features 101
Effects of montelukast treatment and withhdrawal on fractional exhaled nitric oxide and lung function in children with asthma 101
Soluble CD40L as an indicator of platelet Activation in Heart Failure 101
In vivo formation of 8-iso-prostaglandin F2a and aspirin-insensitive thromboxane biosynthesis in unstable angina 100
Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzima-A inhibitor sinvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E. 100
Enhanced lipid peroxidation and platelet activation in the early stages of type 1 diabetes mellitus. Role of Interleukin-6 and disease duration. 100
Signaling pathways involved in lipopolysaccharide stimulation of prostaglandin production by rat hypothalamic astroglial cells 99
Totale 12.912
Categoria #
all - tutte 65.617
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.617


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022452 0 0 0 0 71 9 11 43 45 11 78 184
2022/20231.930 159 197 126 222 189 447 115 134 233 19 39 50
2023/2024801 62 33 60 22 48 256 216 25 2 7 9 61
2024/20252.395 149 524 484 28 19 55 20 91 174 64 277 510
2025/20264.393 429 255 407 464 423 299 801 213 470 364 192 76
2026/20271.456 110 275 248 615 208 0 0 0 0 0 0 0
Totale 16.770